Cite
Retinal ganglion cell dysfunction in preclinical Alzheimer's disease: an electrophysiologic biomarker signature.
MLA
Asanad, Samuel, et al. “Retinal Ganglion Cell Dysfunction in Preclinical Alzheimer’s Disease: An Electrophysiologic Biomarker Signature.” Scientific Reports, vol. 11, no. 1, Mar. 2021, p. 6344. EBSCOhost, https://doi.org/10.1038/s41598-021-85010-1.
APA
Asanad, S., Felix, C. M., Fantini, M., Harrington, M. G., Sadun, A. A., & Karanjia, R. (2021). Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature. Scientific Reports, 11(1), 6344. https://doi.org/10.1038/s41598-021-85010-1
Chicago
Asanad, Samuel, Christian M Felix, Michele Fantini, Michael G Harrington, Alfredo A Sadun, and Rustum Karanjia. 2021. “Retinal Ganglion Cell Dysfunction in Preclinical Alzheimer’s Disease: An Electrophysiologic Biomarker Signature.” Scientific Reports 11 (1): 6344. doi:10.1038/s41598-021-85010-1.